curasan AG receives European license for bone regeneration material with optimised handling features

Top Quote curasan AG, listed in the General Standard of the German Stock Exchange, has received the European approval for Cerasorb® foam. End Quote
  • (1888PressRelease) August 24, 2011 - Kleinostheim - curasan AG, listed in the General Standard of the German Stock Exchange (ISIN: DE 000 549 453 8), has received the European approval for Cerasorb® foam for two different product versions.

    The new synthetic bone regeneration material consists of a combination of Cerasorb with collagen. Its open porous structure permits rapid and deep ingrowth of the bone cells and, thereby, a stable bone remodeling of the im-plant. The material supports the growth of the patient's own bone and is ab-sorbed in the course of the bone building process.

    Depending on the indication, the user can choose between an elastic or malleable product variant.

    „By combining our well-proven synthetic ceramic material with the biological features of collagen, we offer new application forms for easier handling during surgery in addition to our conventional granules and block forms", comments Hans Dieter Rössler, CEO of curasan AG.

    Until other products of the composite line are ready for sale, curasan AG will take over the marketing of Cerasorb® Foam directly, beginning in the course of the current year.

    Background information about curasan AG:
    Exchange listed curasan AG (ISIN: DE 000 549 453 8) is one of the leading companies in the field of regenerative medicine especially in bone and tissue regeneration. In addition to the synthetic Cerasorb bone substitution and regeneration material, the company has developed a future-oriented product pipeline. Some of these various new developments are ready yet for market rollout. These biomaterials will be marketed globally by well-positioned contractual partners. Further products will follow until end of 2012.

    Press Contact:
    curasan AG
    Andrea Weidner
    Tel. +49 (0)6027 40 900-51
    Fax +49 (0)6027 40 900-39
    andrea.weidner ( @ ) curasan dot de

    fr financial relations gmbh
    Jörn Gleisner
    Tel. +49 (0)69 95 90 83 20
    Fax +49 (0)69 95 90 83 99
    j.gleisner ( @ ) finanical-relations dot de

  • FB Icon Twitter Icon In-Icon
Contact Information
  • Andrea Weidner
  • Curasan Ag
  • curasan AG Lindigstraße 4 63801 Kleinostheim Germany
  • 63801
  • Voice: 49 (0)6027 40 900-51
  • Visit our Site